Repetera-utvalda Flashcards
EANO rec:
H3 K27M-mutant diffuse midline glioma, WHO grade 4
- Radiotherapy only.
This tumour type includes the majority of brainstem, thalamic and spinal diffuse gliomas in children and adults. Surgical options are limited and benefits from treatment options beyond radiotherapy have not been established because these tumours are rare and have not been studied in dedicated trials. In these tumours, the MGMT promoter is usually unmethylated. The prognosis of patients with this tumour type is poor.
EANO rec:
H3.3 G34-mutant diffuse hemispheric glioma, WHO grade 4
- Surgery if feasible and Chemoradiotherapy.
These tumours mostly occur in adolescents and young adults and the MGMT promoter is more often methylated than unmethylated. These tumours were previously classified as IDH-wild-type glioblastomas and, thus, a reasonable treatment approach for such patients is chemoradiotherapy
Important stages of Karnofsky performance scale to remember
80-100 - able to carry on normal activity and to work. No special care needed.
50-70 - Unable to work, able to live at home and care for most personal needs; varying amount of assistance needed.
0-40 - Unable to care for self, requires equivalent of institutional or hospital care; disease may be progressing rapidly.
What molecular signs make an astrocytoma grade 4?
- IDH mut AND
- loss of ATRX (ATRX mut) or p53 mutation AND
- CDKN2A/B deletion
What is MGMT?
o6-metylguanihn-DNA-metyltransferase
Something is special about some spinal ependymoma and they even got their own name. What?
MYCN amplified.
What is the definition of an oligodendroglioma in WHO CNS 4?
- 1p/19q codeletion
- IDH mutation
- astrocytic appearance
So, A Diffuse glioma is deemed IDH wt.
What more is needed for diagnosis Glioblastoma IDH wt CNS WHO grade 4?
One or more of the following:
* microvascular proliferation
* Necrosis
* TERTp mutation
* EGFR gene amplificantion
* +7/-10
What molecular signs make an IDH mutant astrocytoma grade 4 if the tumor also have microvascular proliferation and/or necrosis?
An ATRX mutation or a p53 mutation.
what alkylating cyt is used for methylated MGMT tumors?
Temozolomid.
What dubbeldeletion is strongly connected to oligodendroglioma?
1p19q deletion.
What clinical traits are 1p19q codeletion associated with?
better prognosis and better response to cyt treatment. (uns)
What is IDH?
the enzyme isocitratedehydrogenas 1 and 2.
What tumor is H3, G34 mutation associated to?
(pediatric) diffuse hemispheric glioma, H3G34. (WHO grade 4)
What tumor is H3K27 mutations associated to?
(pediatric) diffuse midline glioma, H3K27. (WHO grade 4, more aggressive than H3G34)
What is K-67?
A nuclear antigen that gives information of proliferation. Proliferation index is % positive cell nuclei in the tumor. High=aggressive
What does a P53 mutation suggest?
An astrocytic tumor. ( in oposition to oligodendroglioma)
When is 1p/19q deletion tested?
In all IDH mutated glioma grade II and III w kept ATRX expression.
When is ATRX immunohistochemistry done?
In all astrocytoma and oligodendroglioma, if nuclear ATRX is lost, it is NOT an oligodendroglioma.
When is TERT promotor mutaion controlled?
In IDH wt glioma with grade II or III histology
Loss of ———–expression is a strong indication of a astrocytoma and not a oligodendroglioma.
ATRX
Mutation of ———is a strong indication of Astrocytoma and not Oligodendroglioma
p53
What alteration warants a astrocytoma IDH mutant to go from grade 2/3 to grade 4 independent of microvascular proliferations and necrosis?
Homozygous CDKN2A/B
What is bevacizumab?
An angiogenes inhibiting agent.
What is “RANO”?
Response Assessment in Neuro-Oncology. the size of the contrast enhancing tumorcomponent is measured in a special way. That is combined w info of cortison treatment and clinical status.
Non-contrast enhancing tumors with high T2 or T2 FLAIR intensity are also measured.
Smallest “countable” lesion acording to RANO is 1 cm2.
What are the outcomes in RANO?
- response
- partiell response
- stable disease
- progression
What is the drug used for flourescence based visualization of tumor tissue called?
5-aminolevulinic acid.
What determibes the timing, dosing and scheduling of radiotherapy?
- disease subtype
- age
- KPS
- recidual tumor volume.
When should radiotherapy start after surgery?
3-5 weeks
What is the most common dose of radiotherapy for grade 2-3 gliomas?
50-60 Gy, in 1.8-2 Gy daily fractions.
What does hypofractioned radiotherapy mean?
Higher dose per fraction, and a lower total dose. ex 15x2.67Gy.
How much is added to “the gross tumour volume” to account for microscopic invasion?
1-2 cm.
What are requirements for pharmacological treatment of glioma pt?
- hepatic and renal laboratory values within the normal ranges
- exclusion of major lung or heart disease
- exclusion of ongoing infection
What is Temozolomide?
An oral DNA alkylating agent that penetrates the BBB.
What are the risks with Temozolomide treatment?
After 2-3 weeks:
* myelosuppression - noteably thrombocytopenia as its main dose-limiting toxicity
* hepatic function
What is usually the composition of PCV?
- Lomustine (nitrosurea alkylating)
- Procarbazine
- Vincristine
Therapy recommendations for IDH-mutant 1p/19q codeleted oligodendroglioma WHO grade 2
- surgery
- watch and wait in gross total resection and also possibly for younger (40) w incomplete resection if the tumor has not caused neurological deficits beyond EP.
- If more is deemed necessary:
- Radiotherapy
- PCV.
2nd line treatment for all gliomas
Options determined by KPS, neurologic function and prior treatment.
* repeat surgery
* alkylating chemotherapy
* Re-irradiation
* Experimental therapy
Is there any “rescue” third line treatment for low grade glioma if neither radiotherapy or alkylating worked or patient was intolerant?
Only for IDH mut, 1p/19q codeletion tumors=oligodendrogliomas.
Bevacizumab, but its unknown what effect it would have.
First line treatment for Astrocytoma, IDH mut, WHO 2?
Same as for oligodendroglioma, IDH mutant, 1p19q codeleted.
- GTR, age under 40, no neurologic deficit (except EP)
Wait and see OR radiotherapy (50Gy 1.8fractions) followed by PCV. (or when needed)
Obs progression free survival, but not OS has been shown to be prolonged by early radiotherapy but not by RT at disease progression.
Whats the recomendations for 1st line treatment of grade 3 IDH mut astrocytomas?
The standard of care for IDH-mutant astrocytomas, WHO grade 3 includes resection as feasible or biopsy followed by involved field radiotherapy and maintenance temozolomide (CATNON)88. C: II; L: B.
What is the standard of care after surgery for adults with newly diagnosed glioblastoma who are in good general and neurological condition and are aged <70 years?
CONCOMITANT radiotherapy and chemotherapy with temozolomide (75 mg/m2 DAILY throughout radiotherapy, including at weekends) plus SIX cycles of maintenance temozolomide (150–200 mg/m2, 5 out of 28 days).
Does radiotherapy have a role in the treatment of Glioblastomas?
For decades, radiotherapy (60 Gy in 1.8–2 Gy fractions) has been the standard of care for glioblastoma, approximately doubling median OS duration.
What is first line treatment for Oligodendroglioma grade 3?
For grade 3, usually straight to Radiotherapy followed by PCV.
1st line treatment for Astrocytoma, IDH mutant, WHO grade 4?
Radiotherapy followed by TEMOZOLOMIDE wo/w CONCOMITANT temozolomide
Treatment of Glioblastoma after surgery/biopsy for pt over 70 yo
Patients with tumours lacking MGMT promoter methylation or of unknown MGMT promoter methylation status should be treated with hypofractionated radiotherapy alone. Those with tumours with MGMT promoter methylation status should receive temozolomide alone (5 out of 28 days until disease progression or for 12 month).
Glioblastoma - what cyto to use in the newly diagnosed setting?
Combining temozolomide with lomustine might extend OS in patients with MGMT promoter-methylated glioblastoma
Glioblastoma - second surgery?
Second surgery is an option for ~20–30% of patients, commonly with symptomatic but circumscribed relapses diagnosed not earlier than 6 months after initial surgery. Second surgery earlier than 6 months after initial surgery increases the risk of unnecessary intervention on the basis of pseudoprogression and is unlikely to provide durable benefit if the initial surgery followed by radiotherapy did not provide tumour control for more than a few months. ( If the reason was not inadequate surgery)
EANO _ rec:
Does it matter if a glioblastoma patient has a methylated MGMT promotor?
Temozolomide might only be active in patients with MGMT promoter-methylated tumours whereas its activity in patients with MGMT promoter-unmethylated tumours is probably marginal
EANO _ rec:
The findings of MGMT methylation dependency for reslut of treatment has changed rec. for elderly (over 70 yo). How?
Elderly patients not considered candidates for temozolomide chemoradiotherapy should be treated on the basis of MGMT promoter methylation status (NOA-08, Nordic Trial) with radiotherapy (such as 15 × 2.66 Gy) or temozolomide (5 out of 28 days) alone
EANO rec:
Steroids in glioblastoma?
Steroids should not be given to treat asymptomatic or minimally symptomatic oedema and should be tapered as soon as possible, considering their unfavourable safety profile upon long-term administration. Furthermore, steroid use has been shown to be a negative prognostic factor for OS in patients with glioblastoma from three separate large cohorts123 and might interfere with the efficacy of radiotherapy, chemotherapy and immunotherapy.
How many % of brain tumors are constituted by intracranial germ cell tumors?
about 1%
The male:female ratio is interresting in the non-germinatous tumors of the pineal. how does it look?
M:F = 9:1
As germinomas account for 60-80% of all germ cell tumors intracranially, a dichotomized expression for germ cell tumors are commonly used. Which?
- germinomas
- non-germinatous germ cells
where are germ cell tumors usually located?
They are midline clustered with a predilection of the PINEAL (2x all other sites) and suprasellar regions.
Compare prognosis of germinomas and non-germinomatous tumors.
- germnomas are exquisitely radiosensitive and cure ashived with radiation alone in 80-90% of pt.
- Non-germonomatous tumors have survvival rate of 40-70%
Where are neurohypophyseal tumors situated?
In the neurohypophys - posterior part of the pituitary gland
What are the three most common abnormalities in the pituitary gland?
- Pituitary adenoma
- Rathkes cleft cyst
- Craniopharyngeoma
differential diagnostics for the pituitary stalk (mixed adult and children)
- Rathces cleft cyst
- craniopharyngeoma
- germinoma
- eosinophilic granuloma
- metastasis
*(lymphoma)
Differential diagnostics of the optic chiasm itself
- gliomas
- MS
What are the differential diagnostics in the hypothalamus?
No1 = Gliomas.
In children:
* Hamartomas
* Germinomas
* Eosinophilic granuloma
The cavernous sinus lies just lateral to the hypophysis. What is the segment of ICA just cephalade to the cavernous sinus called? And what structures in the sellar/suprasellar region is it close to?
It is the supracavernous segment. It lies just lateral to the pituitary stalk.
What structures run in the cavernous sinus?
CN III, CN IV, CN VI and V1 (these 4 then exit through supraorbital fissure) AND V2 (that exit through rotundum and then infraorbital fissure).
Which of the CN is located more medially in the sinus and run just caudal to the carotid artery?
Abducens. CN VI.
What is the normal pathway for bacteria and fungal infections to spread from the sphenoid sinus intracranially?
Via the cavernous sinus.
Difine a pituitary microadenoma
Less than 10mm
What is the first radiological diff diagnosis of microadenoma?
Rathkes cleft cysts.